Piloting a Healthy Aging Cohort in Manitoba

NCT06100224 | Recruiting

• 1 other identifier: HS25790 (H2022:393)
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to set up and pilot baseline data collection for a prospective cohort designed to explore the relationships between medical fitness facility usage, lifestyle behaviours and health outcomes as individuals age. Additionally, this pilot study will set up the overall objectives for the larger, prospective cohort study using a public engagement participatory approach with public/patient partners involved in determining which healthy aging outcomes to include.

Conditions

Healthy Aging

Keywords

Medical fitness facility

Outcome Measures

Primary Outcomes (29)

• Health History

  Collected using the Chronic Conditions, Health History and Facility Usage Questionnaire and the Family Medical History Questionnaire

  At baseline an Year 1

• Fitness Level

  Measured by volitional oxygen intake, otherwise known as VO2 max, using the Ebbeling Treadmill Test (a submaximal walking test)

  At baseline an Year 1

• Diet

  Measured using the Mindful Eating Questionnaire and the 3 Factor Eating Questionnaire

  At baseline an Year 1

• Dietary Intake

  The RxFood App will be used to measure dietary intake over 3 full days.

  At baseline an Year 1

• Physical Activity

  Measured using the International Physical Activity Questionnaire - Short form (IPAQ-S)

  At baseline an Year 1

• Physical Activity Assessment

  An Actigraph activity monitor will be used to measure physical activity for 7 days, wtih participants asked to wear the monitor at all times.

  At baseline an Year 1

• Sleep Quality Assessment

  Measured using the Pittsburgh Sleep Quality Index Questionnaire (PSQI), an effective instrument used to measure the quality and patterns of sleep in adults. It differentiates "poor" from "good" sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction.

  At baseline and Year 1

• Sleep Assessment

  An ActiGraph activity monitor will be used to measure sleep quality patterns for 7 days, wtih participants asked to wear the monitor at all times, including when they sleep.

  At baseline and Year 1

• Stress

  The Perceived Stress Questionnaire (PSQ) will be completed to assess stressful life events and circumstances that tend to trigger or exacerbate disease symptoms.

  At baseline and Year 1

• Cognition Assessment

  The Montreal Cognitive Assessment Score (MoCA) will be used to give insight into how participants mentally process information.

  At baseline and Year 1

• Body Weight

  Body weight will be measured.

  At baseline and at Year 1

• Body Mass Index (BMI)

  Body Mass Index will be measured

  At baseline and at Year 1

• Waist circumference

  Waist circumference will be measured

  At baseline and at Year 1

• Blood Pressure

  Blood pressure while awake, while asleep, and total will be measured using an ambulatory blood pressure monitor, worn for 3 consecutive days.

  At baseline and at Year 1

• Frailty

  The Short Physical Performance Battery (balance test, gait speed, and chair stand) and handgrip strength with be collected to measure frailty.

  At baseline and at Year 1

• Facility Usage

  Participants will complete a questionnaire on attendance in hours per week, and # of times per week, and specific program/facility usage at the Wellness Institute. The Wellness Institute swipe data will be used to record the number of times swiped per week and per month since joining.

  At baseline and at Year 1

• Cholesterol

  Total cholesterol, HDL-C, LDL-C, triglycerides, total cholesterol/HDL ratio

  At baseline and at Year 1

• HbA1c

  Hemoglobin A1C

  At baseline and at Year 1

• eGFR

  Estimated glomerular filtration rate.

  At baseline and at Year 1

• uACR

  Urine albumin to creatinine ratio

  At baseline and at Year 1

• 10-Year Risk of Cardiovascular Disease

  Measured using the Framingham Risk Score

  At baseline and at Year 1

• Cardiovascular Assessment

  Identification of Metabolic Syndrome and the Framingham Risk Score will be measured.

  At baseline and at Year 1

• Body Composition

  DEXA scan measurements including total mass, fat mass, lean mass, % fat, visceral adipose tissue, total body bone mineral density), and relative skeletal muscle index (RSMI) will be collected.

  At baseline and at Year 1

• Social Determinants of Health

  Access to general medical and dental care, postal code, household income, education level and marital status will be collected.

  At baseline and at Year 1

• Wellbeing - Quality of Life

  the EQ-5D-5L will be collected to measure quality of life.

  At baseline and at Year 1

• Wellbeing - Loneliness

  The UCLA Loneliness Scale will be sued to measure loneliness.

  At baseline and at Year 1

• Wellbeing - Life Satisfaction

  The Satisfaction With Life Scale will be used to measure life satisfaction

  At baseline and at Year 1

• Wellbeing - Self-efficacy

  The Multidimensional Health Locus of Control (MHLC) Scale Form A will be used to measure self-efficacy

  At baseline and at Year 1

• Wellbeing - Depression

  The Center for Epidemiologic Studies Short Depression Scale (CES-D-10) will be used to measure depression

  At baseline and at Year 1

Eligibility Criteria

• Age: 30 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited from individuals that attend The Wellness Institute. This study is a pilot with the number of recruited participants set as the initial 20 plus an additional anticipated 80, totaling 100 participants.

You may qualify if:

• Male or female, aged 30 years or above.
• Able to communicate in English and provide written informed consent
• Current member of the Wellness Institute
• Access to a device such as an android or iOS smartphone or tablet for use with the dietary tracking application.

You may not qualify if:

• Female participant who is pregnant or lactating
• Employees of the Wellness Institute
• Involvement in the planning and/or conduct of the study

Sponsors & Collaborators

• University of Manitoba: lead
• Seven Oaks Hospital Chronic Disease Innovation Centre: collaborator
• The Wellness Institute Powered by Seven Oaks General Hospital: collaborator
• Medical Fitness Association: collaborator

Study Sites (1)

Seven Oaks Hospital Chronic Disease Innovation Centre

Winnipeg, Manitoba, R2V 3M3, Canada

RECRUITING

Study Officials

• Claudio Rigatto, MD

  University of Manitoba

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Kathy Cherepak, BSc

CONTACT

204-632-3541; kcherepak@sogh.mb.ca

Claudio Rigatto, MD

CONTACT

204-631-3834; CRIGATTO@sbgh.mb.ca

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Medicine, Nephrologist

Study Record Dates

• First Submitted: October 20, 2023
• First Posted: October 25, 2023
• Study Start: April 1, 2024
• Primary Completion: May 1, 2026
• Study Completion: May 1, 2026
• Last Updated: November 28, 2025

Record last verified: 2025-11

Locations

CA (1)